GLPBio

Isorhamnetin

Catalog No.: GN10023Purity:>99.00%Synonyms: 3'Omethyl Quercetin
Isorhamnetin is a flavonoid compound extracted from the traditional Chinese medicine Hippophae rhamnoides L., possessing various biological activities including antioxidant, anti-inflammatory, anticancer, and neuroprotective effects.

Products are for research use only. Not for human use. We do not sell to patients.


Isorhamnetin
Cas No.: 480-19-3
10mM (in 1mL DMSO)In Stock
$44.00
1
1mgIn Stock
$17.00
1
5mgIn Stock
$37.00
1
10mgIn Stock
$62.00
1
25mgIn Stock
$136.00
1
50mgIn Stock
$244.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

Isorhamnetin is a flavonoid compound extracted from the traditional Chinese medicine Hippophae rhamnoides L., possessing various biological activities including antioxidant, anti-inflammatory, anticancer, and neuroprotective effects[1, 2]. Isorhamnetin exerts its effects by regulating multiple cellular signaling pathways (such as NF-κB and PI3K/AKT), and is beneficial for cardiovascular health, diabetes, and potentially neurodegenerative diseases[3].

In vitro, treatment of A549 cells with Isorhamnetin (31.6, 63.2µM) for 24h resulted in the accumulation of A549 cells in the G0/G1 phase, a decrease in the number of cells in the S phase, and induced apoptosis. Isorhamnetin upregulated the expression of apoptotic genes Bax, caspase-3, and p53, and downregulated the expression of Bcl-2, cyclin D1, and PCNA proteins[4]. Treatment of HepG2 cells with Isorhamnetin (10-100µM) enhanced the nuclear translocation of NF-E2-related factor 2 (Nrf2) in a dose- and time-dependent manner, increased antioxidant response element (ARE) reporter gene activity, and elevated the protein levels of heme oxygenase-1 (HO-1) and glutamate cysteine ligase (GCL), and increased intracellular glutathione (GSH) levels[5].

In vivo, Isorhamnetin (5mg/kg) administered via intraperitoneal injection for 7 days to rats with a chronic cardiotoxicity model significantly reduced myocardial damage, decreased serum cardiac enzyme release, and reduced myocardial vacuolization[6]. Isorhamnetin (5mg/kg) administered via intraperitoneal injection to mice with experimental stroke significantly reduced cerebral edema, improved blood-brain barrier function and neurological function, and upregulated the gene expression of tight junction proteins (including occludin, ZO-1, and claudin-5)[7].

References:
[1] Khaled R. Biological activities of isorhamnetin: A review[J]. Plantae Scientia, 2020, 3(5): 78-81.
[2] Teng B, Lu Y H, Wang Z T, et al. In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells[J]. Pharmacological research, 2006, 54(3): 186-194.
[3] Mao Y, Zha Y, Zang Y, et al. Isorhamnetin improves diabetes-induced erectile dysfunction in rats through activation of the PI3K/AKT/eNOS signaling pathway[J]. Biomedicine & Pharmacotherapy, 2024, 177: 116987.
[4] Li Q, Ren F Q, Yang C L, et al. Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo[J]. Asian Pacific Journal of Cancer Prevention, 2015, 16(7): 3035-3042.
[5] Yang J H, Shin B Y, Han J Y, et al. Isorhamnetin protects against oxidative stress by activating Nrf2 and inducing the expression of its target genes[J]. Toxicology and applied pharmacology, 2014, 274(2): 293-301.
[6] Sun J, Sun G, Meng X, et al. Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro[J]. PloS one, 2013, 8(5): e64526.
[7] Zhao J J, Song J Q, Pan S Y, et al. Treatment with isorhamnetin protects the brain against ischemic injury in mice[J]. Neurochemical Research, 2016, 41(8): 1939-1948.

Protocol

Cell experiment [1]:

Cell lines

A549 cells

Preparation Method

A549 cells were incubated with 10, 20µg/mL (31.6, 63.2µM) of Isorhamnetin for 24h. After treatment, cells were washed with PBS and fixed in ice-cold 75% ethano. Cellular DNA was stained with 0.05% propidium iodide (PI) for 20min at 4°C in darkness. The cell cycle distribution and apoptotic cells were detected with FACScan.

Reaction Conditions

31.6, 63.2µM; 24h

Applications

Isorhamnetin treatment resulted in an accumulation of A549 cellsin the G0/G1 phase with concomitant losses in the S phase.
Animal experiment [2]:

Animal models

Sprague-Dawley rats

Preparation Method

Rats were randomly assigned to four groups. (1) Control group: rats were intraperitoneally (i.p.) injected with saline; (2) Doxorubicin (Dox) group: rats were treated with Dox i.p. with a dose of 3mg/kg every other day for a cumulative dose of 9mg/kg, as previously described; (3) Isorhamnetin group (Iso): rats were pretreated with Isorhamnetin at a dose of 5mg/kg i.p. every day for 6 days; (4) Isorhamnetin doxorubicin group: rats were treated with Isorhamnetin at a dose of 5mg/kg i.p. prior to Dox for 7 days. After 28 days, the rats were then sacrificed and the hearts were removed rapidly. The relative heart weight index (heart weight-to-body weight ratio) was determined. Blood was collected and centrifuged. The serum samples were assayed for LDH, CK, and AST activities. The left ventricles of the hearts were used for histopathological examination and other analyses.

Dosage form

5mg/kg; 7 days; i.p.

Applications

Daily pretreatment with Isorhamnetin (5mg/kg, i.p.) for 7 days was found to reduce Dox-induced myocardial damage significantly, including the decline of cardiac index, decrease in the release of serum cardiac enzymes and amelioration of heart vacuolation.

References:
[1] Li Q, Ren F Q, Yang C L, et al. Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo[J]. Asian Pacific Journal of Cancer Prevention, 2015, 16(7): 3035-3042.
[2]Sun J, Sun G, Meng X, et al. Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro[J]. PloS one, 2013, 8(5): e64526.

Product Documents

Purity:>99.00%Appearance:A solid

Chemical Properties

CAS No.
480-19-3
Synonyms
3'Omethyl Quercetin
Chemical Name
3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one
SMILES
COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O
Molecular Formula
C16H12O7
Molecular Weight
316.27
Solubility
≥ 31.8 mg/mL in DMSO
Storage
Store at -20°C
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Isorhamnetin

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%